A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT01667562 · COMPLETED
Trial details
- NCT number
- NCT01667562
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-20
- Primary completion
- 2017-09-07
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.